文献速递医学教育与科研方法流行病学与生物统计

探讨试验方法学研究纳入弱势群体:少数族裔对延迟同意态度的示例

Exploring the inclusion of under-served groups in trials methodology research: an example from ethnic minority populations' views on deferred consent.
PubMed 文献 · Trials · 2021-09-03

本文探讨延迟同意在急诊研究中促进试验多样性时,少数族裔群体的态度是否被充分代表。文献分析显示相关研究多未能充分代表少数族裔,且族裔分类模糊;延迟同意总体可接受,但少数族裔报告更高程度不可接受,受既往经历和对研究的历史不信任影响。结论强调方法学研究需更具包容性,改善报告与代表性。

要点

  • 延迟同意总体可接受,但少数族裔报告更高程度不可接受。
  • 既往直接或间接经历及对研究的历史不信任影响态度。
  • 方法学研究需改善少数族裔代表性与报告透明度。

核心结论

  • 试验方法学研究应具包容性,需更多努力理解少数族裔等弱势群体对研究的看法以改善参与。
  • 改善少数族裔对研究的信心需在研究全过程中提升代表性,包括研究团队与伦理委员会的多元化。

研究设计与样本

  • 本文为文献综述与观点分析,聚焦少数族裔群体对延迟同意的态度。

主要发现

  • 关于延迟同意等招募方法态度的研究大多未能充分代表少数族裔。
  • 许多研究未报告患者样本构成或未分析特定患者组间差异,族裔分类模糊。
  • 延迟同意总体可接受,但少数族裔报告更高程度不可接受,受既往经历和历史不信任影响。
  • 延迟同意在某些试验中增加黑人参与者入组数,但在其他试验中过度入组可能引发进一步担忧。

临床怎么用

  • 在急诊研究采用延迟同意时,应关注少数族裔群体的态度差异并改善研究代表性。
  • 研究应报告样本族裔构成并分析组间差异,避免族裔分类模糊。
  • 通过多元化研究团队与伦理委员会提升少数族裔对研究的信心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deferred consent is used to recruit patients in emergency research, when informed consent cannot be obtained prior to enrolment. This model of consent allows studies to recruit larger numbers of participants, especially where a surrogate-decision maker may be unavailable to provide consent. Whilst deferred consent offers the potential to promote trial diversity by including under-served groups, it is ethically complex and views about its use amongst these populations require further exploration. The aim of this article is to build upon recent initiatives to improve inclusivity in trials, such as the NIHR INCLUDE project, and consider whether trials methodology research is inclusive, focusing on ethnic minority populations' attitudes towards the use of deferred consent. MAIN TEXT: Findings from the literature suggest that research regarding attitudes toward recruitment methods like deferred consent largely fail to adequately represent ethnic minorities. Many studies fail to report the composition of patient samples or conduct analyses on any differences between specific patient groups. In those that do, the categorisation of ethnic groups is ambiguous. Frequently diversely different groups are considered as more homogenous than they are. Whilst deferred consent is deemed generally acceptable, analysis of patient sub-groups shows that this attitude is not universal. Those from racial and ethnic minority backgrounds reported higher levels of unacceptability, which was impacted by previous first or second-hand experience of its use and historical mistrust in research. However, whilst deferred consent was found to increase the numbers of black participants enrolled in some trials, their over-enrolment in other trials may raise further concerns. CONCLUSIONS: Inclusivity in clinical trials is important, as highlighted by the COVID-19 pandemic. To improve this, we must ensure that methodological studies such as those exploring attitudes to research are inclusive. More effort is needed to understand the views of under-served groups, such as ethnic minorities, toward research in order to improve participation in clinical trials. Our findings echo those from the INCLUDE project, in that better reporting is needed and increasing the confidence of ethnic minority groups in research requires improving representation throughout the research process. This will involve diversifying research teams and ethics committees.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Raven-Gregg T, Shepherd V. Exploring the inclusion of under-served groups in trials methodology research: an example from ethnic minority populations' views on deferred consent. Trials. 2021. PMID: 34479612. doi:10.1186/s13063-021-05568-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。